# CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder (2023 Update)

## Metadata
- **Specialty**: Psychiatry
- **Organization**: Canadian Network for Mood and Anxiety Treatments (CANMAT), International Society for Bipolar Disorders (ISBD)
- **Year**: 2023 (Update to 2018 guidelines)
- **DOI**: [10.1176/appi.focus.20230009](https://doi.org/10.1176/appi.focus.20230009)
- **Source URL**: https://psychiatryonline.org/doi/full/10.1176/appi.focus.20230009

## Scope
Updated evidence-based recommendations for the treatment of bipolar I and II disorder, including acute mania, bipolar depression, and maintenance therapy.

## Key Recommendations

### Acute Mania - First-Line Treatments
Ranked hierarchically based on efficacy for mania, depression, relapse prevention, and tolerability:
- Lithium
- Quetiapine
- Divalproex
- Asenapine
- Aripiprazole
- Paliperidone
- Risperidone
- Cariprazine

### Acute Bipolar Depression - First-Line Treatments
- Quetiapine
- Lurasidone (adjunct or monotherapy)
- Lithium
- Lamotrigine
- Cariprazine

### Maintenance Therapy - First-Line Treatments
- Lithium
- Quetiapine
- Divalproex
- Lamotrigine
- Asenapine

### Key Clinical Guidance

#### Antidepressants
- **Do NOT use antidepressants as monotherapy** for bipolar I depression
- Risk of treatment-emergent affective switch (mania/hypomania)
- If used, combine with mood stabilizer or atypical antipsychotic

#### Cariprazine (New Evidence)
- Three RCTs demonstrate superior efficacy vs. placebo for bipolar I depression
- Approved for acute mania and bipolar depression

#### ECT (Electroconvulsive Therapy)
- Second-line treatment for:
  - Treatment-refractory bipolar depression
  - Severe depression with imminent suicide risk
  - Catatonia
  - Psychotic depression
  - When rapid response is medically necessary

### Monitoring
- Regular mood monitoring
- Metabolic monitoring for atypical antipsychotics
- Lithium levels and renal/thyroid function
- Valproate levels and liver function

## Related Guidelines
- VA/DoD Clinical Practice Guideline for Management of Bipolar Disorder (2023)
- NICE Bipolar Disorder Assessment and Management (2014, updated 2023)
